PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
Global Information Inc.

Press Release


Receive press releases from Global Information Inc.: By Email RSS Feeds:

GiiResearch.com: Forthcoming Patent Expiry of Key Blockbuster Drugs to Benefit Generics Manufacturers


Patent expiry of several major blockbuster drugs worth $150 billion between 2010 and 2017 will fuel the growth of the global generic pharmaceuticals market says new Frost & Sullivan report.

Hartford, CT, January 20, 2012 --(PR.com)-- Global Information Inc. (GII) is pleased to announce a new market research report, “Generic Pharmaceuticals Market – A Global Analysis” by Frost & Sullivan.

The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to the patent expiration of key blockbuster drugs and the judicious cost containment efforts of governments and healthcare service providers worldwide. At the same time, the balance in terms of healthcare expenditure and sales revenue is poised to shift from developed to emerging markets such as India, China, Brazil, Russia, Turkey and South Korea, as huge potential still remains untapped in these countries.

New analysis from Frost & Sullivan’s new report finds that the global generic pharmaceuticals market earned revenues of $123.85 billion in 2010 and estimates this to reach $ 231.00 billion in 2017 at a compound annual growth rate (CAGR) of 9.29 per cent from 2011-2018. Regions covered in the research include the United States, Europe (Germany, the United Kingdom, France, Spain, and Italy) and Asia (India and China).

"The patent expiry of several major blockbuster drugs worth $ 150 billion between 2010 and 2017 will fuel the growth of the global generic pharmaceuticals market," notes Frost & Sullivan Research Analyst Aiswariya Chidambaram. "The trend is shifting towards less competitive, yet commercially attractive segments such as difficult-to-produce generics, specialty generics and biosimilars."

Leading global generic pharmaceutical manufacturers have been proactive in forging strategic alliances with branded pharmaceutical companies for marketing rights and exclusivity in producing generic versions of blockbuster drugs such as LIPITOR, Cozaar and Crestor, among others. Market leaders such as Teva, Sandoz and Mylan are increasingly focused on biosimilars, as this segment provides a competitive edge and presents huge profit margins.

While these are positive signs for market participants, a potential dampener is the progressively stringent regulations and price control measures being imposed by governments. These have tended to squeeze profit margins for generic manufacturers.

"The increase in the prevalence of chronic disorders, newly reported diseases and ageing populations have resulted in tremendous pressure being placed on governments to implement cost containment measures and curb rampant healthcare expenditure," adds Aiswariya.

As competition intensifies, generic drug manufacturers will have to make careful choices about the product segments that they wish to compete in and the appropriate time of entry into the market.

"Large multinational generic firms need to adopt a differentiated approach by opting for products with technologically challenging formulations, products which require significant regulatory support and products with limited availability of active pharmaceutical ingredients (APIs)," advises Aiswariya. "Small and medium-sized firms should focus on products with relatively higher profit margins."

For more information, visit: http://www.giiresearch.com/report/fs227336-generic-pharmaceuticals-market-global-analysis.html

View complete list of generic drugs market research reports: http://www.giiresearch.com/topics/PH08_en.shtml

About Global Information Inc.
Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

###
Contact Information
Global Information Inc.
Yuko Ueki
860-674-8796
Contact
http://www.GiiResearch.com

Click here to view the list of recent Press Releases from Global Information Inc.
Promote Your Business